Merit says the adoption of digital technology has enabled it to construct biopharmaceutical facilities three times faster than the industry standard. According to Merit, a major issue in the construction space is the scarce implementation of digital technologies. However, the firm decided to rethink, reengineer, and reform how to deliver a construction project, leading to the creation of an integrated IT platform and digital form of construction using Revit, a software to plot and track stages in the building’s…
Tuesday, May 17, 2022 Daily Archives
Avantor and Cytovance team to address $1.5bn plasmid DNA market
The advanced therapy pipeline is driving demand says Avantor, which has collaborated with Cytovance to offer an expanded plasmid DNA service. “The demand for plasmid DNA, especially at cGMP-grade, supporting advanced therapeutic modalities is growing rapidly,” said Ger Brophy, EVP of Biopharma Production at Avantor. He told BioProcess Insider it is being driven by the growing, early-stage pipeline of cell and gene therapies, DNA and RNA vaccines, and gene editing technologies. “We estimate that the total addressable market for plasmid DNA…